NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled
NCT05634577 2025-06-19A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical CarcinomaM.D. Anderson Cancer CenterPhase 2 Terminated3 enrolled 7 charts